This is a real-world medical entrance exam question, please give the true answer based on the question and selection. Topic name: C.N.S, Subject name: Pharmacology
[{'content': 'New drug for tardive dyskinesia: \nSelect and explain. \nA. Safinamide, B. Tetrabenazine, C. Valbenazine, D. Deutetrabenazine', 'role': 'user'}, {'content': "Answer: C \nExplanation: C i.e. ValbenazineRef: https://www. accessdata. fda. gov/drugsatfda_docs/label/2017/209241lbl. pdfExplanation:Valbenazine:Vesicular monoamine transporter 2 (VMAT2) inhibitor.Specifically indicated for the treatment of adults with tardive dyskinesia.Supplied as a capsule for oral administration.Tetrabenazine:Centrally-acting dopamine depletor.Selective and reversible.Used in chorea associated with Huntington's disease.Deutetrabenazine: (Approved in April 2017)It is a vesicular monoamine transporter 2 (VMAT2) inhibitor.Specifically indicated for the treatment of chorea associated with Huntington's disease.Supplied as a tablet for oral administration.Safinamide:MAO B inhibitor.Approved for treatment of on off phenomena seen with levodopa in parkinson's disease.", 'role': 'assistant'}]